Purifying chylous plasma by precluding triglyceride via carboxylated polyethersulfone microfiltration membrane

doi:10.1016/j.cjche.2022.05.011

中国化学工程学报 ›› 2022, Vol. 49 ›› Issue (9): 130-139.DOI: 10.1016/j.cjche.2022.05.011

• Special Column: Membranes for Life Science • 上一篇下一篇

Purifying chylous plasma by precluding triglyceride via carboxylated polyethersulfone microfiltration membrane

Yang Liu^1,2, Qiu Han¹, Guiliang Li^1,2, Haibo Lin¹, Fu Liu^1,2, Gang Deng³, Dingfeng Lv⁴, Weijie Sun⁴

1. Ningbo Institute of Materials Technology & Engineering, Chinese Academy of Sciences, Ningbo 315000, China;
2. University of Chinese Academy of Sciences, Beijing 100049, China;
3. The Ningbo Central Blood Station, Ningbo 315099, China;
4. Department of Blood Transfusion, Ningbo First Hospital, Ningbo 315010, China

收稿日期:2021-09-29 修回日期:2022-04-30 发布日期:2022-10-19
通讯作者: Fu Liu,E-mail:fu.liu@nimte.ac.cn
基金资助:
This work is financially supported by Natural Science Foundation of Ningbo City (2018A610026), Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars (LR20E030002), Ten thousand plan-high level talents special support plan of Zhejiang province, China (ZJWR0108020) and Youth Innovation Promotion Association of Chinese Academy of Science (2014258).

Purifying chylous plasma by precluding triglyceride via carboxylated polyethersulfone microfiltration membrane

Yang Liu^1,2, Qiu Han¹, Guiliang Li^1,2, Haibo Lin¹, Fu Liu^1,2, Gang Deng³, Dingfeng Lv⁴, Weijie Sun⁴

1. Ningbo Institute of Materials Technology & Engineering, Chinese Academy of Sciences, Ningbo 315000, China;
2. University of Chinese Academy of Sciences, Beijing 100049, China;
3. The Ningbo Central Blood Station, Ningbo 315099, China;
4. Department of Blood Transfusion, Ningbo First Hospital, Ningbo 315010, China

Received:2021-09-29 Revised:2022-04-30 Published:2022-10-19
Contact: Fu Liu,E-mail:fu.liu@nimte.ac.cn
Supported by:
This work is financially supported by Natural Science Foundation of Ningbo City (2018A610026), Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars (LR20E030002), Ten thousand plan-high level talents special support plan of Zhejiang province, China (ZJWR0108020) and Youth Innovation Promotion Association of Chinese Academy of Science (2014258).

摘要/Abstract

摘要： Precluding the excessive lipoproteins from plasma rapidly and effectively is highly needed for biomedical detection and reducing plasma product scrap in blood donation stations. The current centrifugation procedure is high-cost and time-consuming. Herein, we fabricated an anionic microfiltration polyethersulfone (PES) membrane modified by interface swelling and implanting of acrylic acid (AA) for screening out large particle lipoprotein chylomicron (CM) and adsorbing cationic very low-density lipoproteins (VLDL). To improve the separation efficiency, a two-stage filtration through carboxylated polyethersulfone microfiltration membranes with the mean pore size of 0.45 and 0.22 μm respectively were conducted. Attenuated total reflection Fourier transform infrared technique (ATR-FTIR), water contact angle (WCA), Zeta potential and scanning electron microscope (SEM) were employed to characterize the modified membrane. To test the effectiveness of this membrane, plasma flux and concentration variation of plasma components were examined to study the purification effectiveness. Furthermore, the hemocompatibility of modified membranes was tested to confirm its practicability on blood-contacting materials. The carboxylated polyethersulfone microfiltration membrane shows its promising potential application to purify chylous plasma.

关键词: Chylous plasma, Chylomicrons, Very low-density lipoproteins, Carboxylated polyethersulfone microfiltration membrane

Abstract: Precluding the excessive lipoproteins from plasma rapidly and effectively is highly needed for biomedical detection and reducing plasma product scrap in blood donation stations. The current centrifugation procedure is high-cost and time-consuming. Herein, we fabricated an anionic microfiltration polyethersulfone (PES) membrane modified by interface swelling and implanting of acrylic acid (AA) for screening out large particle lipoprotein chylomicron (CM) and adsorbing cationic very low-density lipoproteins (VLDL). To improve the separation efficiency, a two-stage filtration through carboxylated polyethersulfone microfiltration membranes with the mean pore size of 0.45 and 0.22 μm respectively were conducted. Attenuated total reflection Fourier transform infrared technique (ATR-FTIR), water contact angle (WCA), Zeta potential and scanning electron microscope (SEM) were employed to characterize the modified membrane. To test the effectiveness of this membrane, plasma flux and concentration variation of plasma components were examined to study the purification effectiveness. Furthermore, the hemocompatibility of modified membranes was tested to confirm its practicability on blood-contacting materials. The carboxylated polyethersulfone microfiltration membrane shows its promising potential application to purify chylous plasma.

Key words: Chylous plasma, Chylomicrons, Very low-density lipoproteins, Carboxylated polyethersulfone microfiltration membrane

Yang Liu, Qiu Han, Guiliang Li, Haibo Lin, Fu Liu, Gang Deng, Dingfeng Lv, Weijie Sun. Purifying chylous plasma by precluding triglyceride via carboxylated polyethersulfone microfiltration membrane[J]. 中国化学工程学报, 2022, 49(9): 130-139.

参考文献

[1] J. Ju, F.X. Liang, X.X. Zhang, R. Sun, X.G. Pan, X.Y. Guan, G.N. Cui, X. He, M.Y. Li, Advancement in separation materials for blood purification therapy, Chin. J. Chem. Eng. 27 (6) (2019) 1383-1390
[2] M. Axmann, E. Sezgin, A. Karner, J. Novacek, M.D. Brodesser, C. Röhrl, J. Preiner, H. Stangl, B. Plochberger, Receptor-independent transfer of low density lipoprotein cargo to biomembranes, Nano Lett. 19 (4) (2019) 2562-2567
[3] C.L. Zhu, Y.N. Xia, Biomimetics:Reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications, Chem. Soc. Rev. 46 (24) (2017) 7668-7682
[4] C. Mikl, J. Peters, M. Trapp, K. Kornmueller, W.J. Schneider, R. Prassl, Softness of atherogenic lipoproteins:A comparison of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) using elastic incoherent neutron scattering (EINS), J. Am. Chem. Soc. 133 (34) (2011) 13213-13215
[5] H.Y. Sun, S.F. Chen, M.D. Lai, T.T. Chang, T.L. Chen, P.Y. Li, D.B. Shieh, K.C. Young, Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins, Clin. Chimica Acta 411 (5-6) (2010) 336-344
[6] T. Gautier, V. Deckert, M. Nguyen, C. Desrumaux, D. Masson, L. Lagrost, New therapeutic horizons for plasma phospholipid transfer protein (PLTP):Targeting endotoxemia, infection and sepsis, Pharmacol. Ther. 236 (2022) 108105
[7] B.J. Cochran, K.L. Ong, B. Manandhar, K.A. Rye, High density lipoproteins and diabetes, Cells 10 (4) (2021) 850
[8] S.H. Choi, H.N. Ginsberg, Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance, Trends Endocrinol. Metab. 22 (9) (2011) 353-363
[9] A. Kumari, K.K. Kristensen, M. Ploug, A.L. Winther, The importance of lipoprotein lipase regulation in atherosclerosis, Biomedicines 9 (7) (2021) 782
[10] A.M. Chamberlain, A.R. Folsom, P.J. Schreiner, E. Boerwinkle, C.M. Ballantyne, Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status:The Atherosclerosis Risk in Communities (ARIC) Study, Atherosclerosis 200 (2) (2008) 322-328
[11] T. Shoji, S. Hatsuda, S. Tsuchikura, K. Shinohara, E. Kimoto, H. Koyama, M. Emoto, Y. Nishizawa, Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis, Atherosclerosis 202 (2) (2009) 582-588
[12] I.E. Allijn, W. Leong, J. Tang, A. Gianella, A.J. Mieszawska, F. Fay, G. Ma, S. Russell, C.B. Callo, R.E. Gordon, E. Korkmaz, J.A. Post, Y.M. Zhao, H.C. Gerritsen, A. Thran, R. Proksa, H. Daerr, G. Storm, V. Fuster, E.A. Fisher, Z.A. Fayad, W.J.M. Mulder, D.P. Cormode, Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level, ACS Nano 7 (11) (2013) 9761-9770
[13] J. Pekkanen, S. Linn, G. Heiss, C.M. Suchindran, A. Leon, B.M. Rifkind, H.A. Tyroler, Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease, N. Engl. J. Med. 322 (24) (1990) 1700-1707
[14] R. Bambauer, R. Schiel, R. Latza, Low-density lipoprotein apheresis:An overview, Ther. Apher. Dial. 7 (4) (2003) 382-390
[15] H. Itabe, N. Sawada, T. Makiyama, T. Obama, Structure and dynamics of oxidized lipoproteins in vivo:Roles of high-density lipoprotein, Biomedicines 9 (6) (2021) 655
[16] L.R. Engelking, Textbook of Veterinary Physiological Chemistry (Third Edition), Academic Press, Boston (2015) 411-415
[17] G.R. Bayly, Clinical Biochemistry:Metabolic and Clinical Aspects (Third Edition), Churchill Livingstone, London (2014) 702-736
[18] J.P.D. Reckless, J.M. Lawrence, Encyclopedia of Food Sciences and Nutrition (Second Edition), Academic Press, Oxford (2003) 3183-3192
[19] J.M. Johnston, A. Angyal, R.C. Bauer, S. Hamby, S.K. Suvarna, K. Baidžajevas, Z. Hegedus, T.N. Dear, M. Turner, H.L. Wilson, A.H. Goodall, D.J. Rader, C.C. Shoulders, S.E. Francis, E. Kiss-Toth, Myeloid Tribbles 1 induces early atherosclerosis via enhanced foam cell expansion, Sci. Adv., 5 (2019) eaax9183
[20] D. Vojinovic, D. Radjabzadeh, A. Kurilshikov, N. Amin, C. Wijmenga, L. Franke, M.A. Ikram, A.G. Uitterlinden, A. Zhernakova, J. Fu, R. Kraaij, C.M. van Duijn, Relationship between gut microbiota and circulating metabolites in population-based cohorts, Nat. Commun. 10 (1) (2019) 5813
[21] A.J. Lusis, Atherosclerosis, Nature 407 (6801) (2000) 233-241
[22] J. Shi, Status analysis and evaluation of the blood scrap rate from 2015-2017 for a blood center in China, Transfus. Clin. Biol. 27 (3) (2020) 109-114
[23] T. Bosch, Therapeutic apheresis:State of the art in the year 2005, Ther. Apher. Dial. 9 (6) (2005) 459-468
[24] G. Pütz, J. Eckes, O. Schmah, K. Winkler, H. Wieland, Elimination of liposomes by different separation principles used in low-density lipoprotein apheresis, Ther. Apher. Dial. 12 (1) (2008) 2-12
[25] Y. Matsuda, P.S. Malchesky, Y. Nosé, Assessment of currently available low-density lipoprotein apheresis systems, Artif. Organs 18 (1) (1994) 93-99
[26] M. Susree, M. Anand, Importance of initial concentration of factor VIII in a mechanistic model of in vitro coagulation, Acta Biotheor. 66 (3) (2018) 201-212
[27] K.C. Maki, O.M. Palacios, E. Lindner, K.M. Nieman, M. Bell, J. Sorce, Replacement of refined starches and added sugars with egg protein and unsaturated fats increases insulin sensitivity and lowers triglycerides in overweight or obese adults with elevated triglycerides, J Nutr 147 (7) (2017) 1267-1274
[28] I.R. Corbin, H. Li, J. Chen, S. Lund-Katz, R. Zhou, J.D. Glickson, G. Zheng, Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents, Neoplasia 8 (6) (2006) 488-498
[29] C.F. Semenkovich, 213-Disorders of Lipid Metabolism, in:L. Goldman, A.I. Schafer (Eds.) Goldman's Cecil Medicine (Twenty Fourth Edition), W.B. Saunders, Philadelphia 2012(1346-1354)
[30] F. Blessing, Y. Wang, D. Nagel, D. Seidel, The efficacy and safety of the new heparin-induced extracorporeal low-density lipoprotein precipitation system (plasmat futura) in comparison with the currently used system (plasmat secura), Ther. Apher. Dial. 8 (1) (2004) 33-38
[31] A. Ramunni, L.F. Morrone, G. Baldassarre, E. Montagna, A. Saracino, P. Coratelli, Effectiveness of long-term heparin-induced extracorporeal LDL precipitation (HELP) in improving coronary calcifications, Int. J. Artif. Organs 26 (3) (2003) 252-255
[32] W. Wang, X.J. Huang, J.D. Cao, P. Lan, W. Wu, Immobilization of sodium alginate sulfates on polysulfone ultrafiltration membranes for selective adsorption of low-density lipoprotein, Acta Biomater. 10 (1) (2014) 234-243

Purifying chylous plasma by precluding triglyceride via carboxylated polyethersulfone microfiltration membrane

Purifying chylous plasma by precluding triglyceride via carboxylated polyethersulfone microfiltration membrane

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价